Eco Animal Health Group (STU:LWA) EBITDA Margin %: 6.62% (As of Sep. 2025) — 55% Below Median


STU:LWA Eco Animal Health Group PLC STU:LWA
67 GF Score
Price €1.00
GF Value €1.14
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eco Animal Health Group EBITDA Margin %?

Eco Animal Health Group STU:LWA -0.99% 67 EBITDA Margin % is 6.62% as of Sep. 2025, which is 55% below its 10-year median of 14.81. GuruFocus rates STU:LWA with a GF Score™ of 67/100 and a GF Value™ of €1.14 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 956 Drug Manufacturers companies, Eco Animal Health Group ranks worse than 52.82% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Eco Animal Health Group's EBITDA for the six months ended in Sep. 2025 was €3.0 Mil. Eco Animal Health Group's Revenue for the six months ended in Sep. 2025 was €45.4 Mil. Therefore, Eco Animal Health Group's EBITDA margin for the quarter that ended in Sep. 2025 was 6.62%.


Eco Animal Health Group  (STU:LWA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Eco Animal Health Group EBITDA Margin % Related Terms


Eco Animal Health Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Eco Animal Health Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eco Animal Health Group EBITDA Margin % Chart

Eco Animal Health Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.21 4.46 8.73 7.31 9.16

Eco Animal Health Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 11.29 0.74 15.18 6.62

STU:LWA vs ZTS, UTHR, VTRS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's EBITDA Margin % falls into.


STU:LWA
67GF Score
Eco Animal Health Group PLC STU:LWA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eco Animal Health Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Eco Animal Health Group's EBITDA Margin % for the fiscal year that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=8.715/95.124
=9.16 %

Eco Animal Health Group's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=3.002/45.362
=6.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 6.62% mean?
Eco Animal Health Group (STU:LWA) has a EBITDA Margin % of 6.62% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eco Animal Health Group and its competitors. This is 55% below median its historical median of 14.81. Over the past decade, Eco Animal Health Group's EBITDA Margin % has ranged from 4.46 to 27.36. According to the industry distribution chart, Eco Animal Health Group ranks #505 out of 956 companies in the Drug Manufacturers industry, placing it in the top 52.8%.
Is Eco Animal Health Group's EBITDA Margin % too high?
Eco Animal Health Group's current EBITDA Margin % of 6.62% is 55% below median its 10-year median of 14.81. Over the past 10 years, this metric has ranged from a low of 4.46 to a high of 27.36. The Drug Manufacturers industry median EBITDA Margin % is 12.52. Eco Animal Health Group's value of 6.62% is 47.1% below this industry median. Based on the distribution chart, Eco Animal Health Group ranks #505 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Eco Animal Health Group has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eco Animal Health Group ranks #505 out of 956 companies for EBITDA Margin %. This places Eco Animal Health Group in the lower half of its industry. The industry median EBITDA Margin % is 12.52. Eco Animal Health Group's value of 6.62% is 47.1% below this benchmark. Historically, Eco Animal Health Group's own EBITDA Margin % has ranged from 4.46 to 27.36 over the past decade. While the company's 10-year median is 14.81 vs. the industry median of 12.52, Eco Animal Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.52, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eco Animal Health Group's current EBITDA Margin % of 6.62% is 47.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eco Animal Health Group and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current EBITDA Margin % is 6.62%, which is 55% below median its own 10-year median of 14.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Based on GuruFocus' analysis, Eco Animal Health Group (STU:LWA) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.14, compared to a current price of €1.00 — trading 12.3% below its estimated fair value. The current EBITDA Margin % is 6.62%, which is 55% below median its 10-year median of 14.81 and 47.1% below the Drug Manufacturers industry median of 12.52. Eco Animal Health Group's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Eco Animal Health Group (STU:LWA), the current EBITDA Margin % is 6.62% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eco Animal Health Group (STU:LWA) Overvalued in 2026?

Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued. The current stock price of €1.00 is trading 12.3% below its estimated GF Value™ of €1.14. GuruFocus considers Eco Animal Health Group to be Modestly Undervalued.

Key valuation signals for STU:LWA:

  • EBITDA Margin %: 6.62% (55% below median its 10-year median of 14.81)
  • GF Value™: €1.14 vs. price of €1.00 (12.3% below fair value)
  • GF Score™: 67/100 with 5 warning signs
  • Industry Position: 47.1% below the Drug Manufacturers median (#505 of 956)

No single metric tells the full story. See the STU:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eco Animal Health Group Business Description

Other Exchanges EAH:UK
Address 100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
67GF Score

Get the complete analysis for STU:LWA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€1.14
GF Value